NASDAQ:GEMP Shareholder Notice: Investigation over Possible Securities Laws Violations by Gemphire Therapeutics Inc
An investigation was announced concerning potential securities laws violations by Gemphire Therapeutics in connection with certain financial statements.
View full press release